Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease

ClinicalTrials.gov ID: NCT04619420

Public ClinicalTrials.gov record NCT04619420. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:46 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study With a Long-Term Extension Treatment Period to Assess the Efficacy and Safety of JNJ-63733657, an Anti-tau Monoclonal Antibody, in Participants With Early Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on clinical decline as measured by the Integrated Alzheimer's Disease Rating Scale (iADRS), a composite of cognition and function.

Study identification

NCT ID
NCT04619420
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
523 participants

Conditions and interventions

Eligibility (public fields only)

Age range
55 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 6, 2021 (Actual)
Primary completion
Oct 17, 2025 (Actual)
Completion
Mar 3, 2026 (Actual)
Last update posted
Nov 5, 2026

2021 – 2026

United States locations

U.S. sites
55
U.S. states
21
U.S. cities
50
Facility City State ZIP Site status
University of Alabama Birmingham Birmingham Alabama 35233 —
Dignity Health Phoenix Arizona 85013 —
Irvine Clinical Research Irvine California 92614 —
University of California San Diego Medical Center La Jolla California 92037 —
University of California - Los Angeles Los Angeles California 90095 —
Stanford University Medical Center Palo Alto California 94304 —
Pacific Research Network Prn San Diego California 92103 —
Syrentis Clinical Research Santa Ana California 92705 —
Yale University School Of Medicine New Haven Connecticut 06510 —
Georgetown University Clinical Research Unit CRU Washington D.C. District of Columbia 20007 —
JEM Research LLC Atlantis Florida 33462 —
Brain Matters Research Delray Beach Florida 33445 —
Neuropsychiatric Research Center of SWFL Fort Myers Florida 33912 —
Clinical NeuroScience Solutions Inc Jacksonville Florida 32256 —
Alphab Global Research Jupiter Florida 33458 —
K2 Medical Research Maitland Florida 32751 —
Tandem Intermediate LLC Maitland Florida 32751 —
Merritt Island Medical Research, LLC Merritt Island Florida 32952 —
University of Miami Miller School of Medicine Miami Florida 33136 —
Miami Jewish Health System Miami Florida 33137 —
Aqualane Clinical Research Naples Florida 34105 —
Renstar Medical Research Ocala Florida 34470 —
Sensible Healthcare Ocoee Florida 34761 —
Axiom Clinical Research of Florida Tampa Florida 33609 —
Stedman Clinical Trials Tampa Florida 33613 —
University of South Florida - Health Byrd Alzheimer Institute Tampa Florida 33613 —
Charter Research The Villages Florida 32162 —
ClinCloud Clinical Research Viera Florida 32904 —
Alzheimers Research and Treatment Center Wellington Florida 33414 —
Palm Beach Neurology and Premier Research Institute West Palm Beach Florida 33407 —
Conquest Research Winter Park Florida 32789 —
The Emory Clinic Atlanta Georgia 30329 —
Sandhill Research Decatur Georgia 30030 —
Great Lakes Clinical Trials Chicago Illinois 60640 —
Alexian Brothers Medical Center - Neuroscience Research Institute Elk Grove Village Illinois 60007 —
Indiana University Indianapolis Indiana 46202 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Anil Nair dba Alzheimer's Disease Center Braintree Massachusetts 02184 —
Hattiesburg Clinic Hattiesburg Mississippi 39401 —
Washington University School Of Medicine St Louis Missouri 63110 —
NeuroCognitive Institute Mount Arlington New Jersey 07856 —
Princeton Medical Institute Princeton New Jersey 08540 —
Advanced Memory Research Institute of NJ Toms River New Jersey 08755 —
Neurological Associates of Albany, PC Albany New York 12208 —
Velocity Clinical Research East Syracuse New York 13057 —
New York University Medical Center New York New York 10016 —
Wake Forest Health Sciences Winston-Salem North Carolina 27157 —
Cleveland Clinic Lou Revo Center for Brain Health Cleveland Ohio 44195 —
Wexner Medical Center at the Ohio State University Columbus Ohio 43221 —
Keystone Clinical Studies LLC Plymouth Meeting Pennsylvania 19462 —
Brown University School of Medicine Providence Rhode Island 02906 —
The University of Texas Health Science Center at Houston Houston Texas 77054 —
Memory Clinic Inc Bennington Vermont 05201 —
University of Virginia Charlottesville Virginia 22903 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04619420, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2026 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04619420 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →